$10.5542
-0.1558[-1.45%]
At close: Apr 24
$10.5542
0[0.00%]
After Hours: 4:09PM EDT
Amicus Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Amicus Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/08/2024 | AM | FOLD | Q1 | -$0.18 | -$0.06 | — | — | $86.27M | $111.96M | — | — | Get Alert |
02/28/2024 | AM | FOLD | Q4 | -$0.19 | -$0.06 | $0.01 | 116.67% | $88.10M | $114.33M | $115.08M | 0.65% | Get Alert |
11/08/2023 | AM | FOLD | Q3 | -$0.12 | -$0.08 | -$0.07 | 12.50% | $81.69M | $101.36M | $103.50M | 2.11% | Get Alert |
08/08/2023 | AM | FOLD | Q2 | -$0.21 | -$0.12 | -$0.15 | -25.00% | $80.73M | $89.87M | $94.50M | 5.16% | Get Alert |
05/10/2023 | AM | FOLD | Q1 | -$0.30 | -$0.15 | -$0.18 | -20.00% | $78.72M | $83.08M | $86.27M | 3.84% | Get Alert |
03/01/2023 | AM | FOLD | Q4 | -$0.29 | -$0.13 | -$0.19 | -46.15% | $82.15M | $86.29M | $88.10M | 2.09% | Get Alert |
11/07/2022 | AM | FOLD | Q3 | -$0.19 | -$0.19 | -$0.12 | 36.84% | $79.55M | $84.22M | $81.69M | -3.00% | Get Alert |
08/04/2022 | AM | FOLD | Q2 | -$0.19 | -$0.22 | -$0.21 | 4.55% | $77.41M | $85.89M | $80.73M | -6.01% | Get Alert |
05/09/2022 | AM | FOLD | Q1 | -$0.25 | -$0.25 | -$0.30 | -20.00% | $66.40M | $77.13M | $78.72M | 2.05% | Get Alert |
02/24/2022 | AM | FOLD | Q4 | -$0.27 | -$0.16 | -$0.29 | -81.25% | $70.57M | $83.28M | $82.15M | -1.35% | Get Alert |
11/09/2021 | AM | FOLD | Q3 | -$0.22 | -$0.18 | -$0.19 | -5.56% | $67.44M | $80.11M | $79.55M | -0.71% | Get Alert |
08/05/2021 | AM | FOLD | Q2 | -$0.20 | -$0.22 | -$0.19 | 13.64% | $62.35M | $73.36M | $77.41M | 5.52% | Get Alert |
05/10/2021 | AM | FOLD | Q1 | -$0.35 | -$0.24 | -$0.25 | -4.17% | $60.52M | $71.65M | $66.40M | -7.32% | Get Alert |
03/01/2021 | AM | FOLD | Q4 | -$0.35 | -$0.23 | -$0.27 | -17.39% | $55.29M | $70.06M | $70.57M | 0.73% | Get Alert |
11/05/2020 | AM | FOLD | Q3 | -$0.24 | -$0.22 | -$0.22 | 0.00% | $48.77M | $65.10M | $67.44M | 3.59% | Get Alert |
08/10/2020 | AM | FOLD | Q2 | -$0.36 | -$0.26 | -$0.20 | 23.08% | $44.13M | $62.38M | $62.35M | -0.04% | Get Alert |
05/07/2020 | AM | FOLD | Q1 | -$0.39 | -$0.28 | -$0.35 | -25.00% | $34.05M | $57.49M | $60.52M | 5.28% | Get Alert |
03/02/2020 | AM | FOLD | Q4 | -$0.41 | -$0.27 | -$0.35 | -29.63% | $32.64M | $52.33M | $55.29M | 5.66% | Get Alert |
11/11/2019 | AM | FOLD | Q3 | -$0.31 | -$0.32 | -$0.24 | 25.00% | $20.60M | $47.66M | $48.77M | 2.32% | Get Alert |
Amicus Therapeutics (FOLD) is scheduled to report earnings on May 8, 2024. The last reported earnings were for reported on February 28, 2024 for Q4.
The Actual EPS was $0.01, which beat the estimate of $-0.06.
The Actual Revenue was $115.1M, which beat the estimate of $114.3M.
Browse earnings estimates, EPS, and revenue on all stocks.